在线精品视频在线观看高清I97人人超I中文字幕在线播放一区I午夜在线资源I九九久久影院I久久免费看毛片I五月婷婷亚洲I久久久精品国产一区二区I日韩 在线观看I在线观看国产一区二区I久久最新网址I日韩成人av在线

Welcome to Linuo Group!HomeBusiness License
  • CN

  • WeChat

  • Mobile Site

  • Search

力諾資訊

Hongjitang holds National Forum for Diagnosis and Treatment of Interstitial Lung Disease through the Integrated Approach of TCM and Western Medicine

2023.07.13

On July 9, the National Forum for Diagnosis and Treatment of Interstitial Lung Disease through the Integrated Approach of TCM and Western Medicine was held at Hongjitang.

Interstitial lung disease (ILD) is one of the four major respiratory diseases with rising prevalence worldwide. The newly founded Committee for Research on ILD Prevention and Treatment Technology unter Shandong Traditional Chinese Medicine Association (STCMA) shall serve as a platform for prescription sharing to improve the effectiveness of ILD treatment with TCM, meanwhile promoting the R&D of new TCM drugs and standardization of diagnosis and treatment of the disease.

During the forum, TCM experts had in-depth exchanges from different perspectives, such as the therapeutic status quo of interstitial lung diseases, epidemiology and medication administration, with focus on Jinbei Koufuye.

Jinbei Koufuye is a TCM product for the treatment of idiopathic pulmonary fibrosis. It shows great clinical efficacy and less adverse reactions, helping improve the life quality of patients. The Development of Jinbei Koufuye and its Application in Respiratory Diseases, a research project carried out by Hongjitang TCM Institute, won the first prize of the first Shandong Traditional Chinese Medicine Industry Science and Technology Award.